NCT01919723View on ClinicalTrials.gov

Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor

Ticagrelor loading dose

DRUG

Eptifibatide

i.v. infusion

Trial Locations (2)

35294

University of Alabama, Birmingham

45267

University of Cincinnati, Cincinnati

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Alabama at Birmingham

OTHER